An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD
Clinical trial NCT06215261 · COMPLETED
Trial details
- NCT number
- NCT06215261
- Sponsor
- Transcend Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-04
- Primary completion
- 2025-09-23
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.